Featured Research

from universities, journals, and other organizations

PET Changes Staging And Treatment For Newly Diagnosed And Recurrent Lung Cancer Patients

Date:
November 5, 2001
Source:
Society Of Nuclear Medicine
Summary:
Positron Emission Tomography (PET) can have a dramatic impact on patient staging and subsequent treatment of persons recently diagnosed or with suspected recurrent non–small cell lung cancer (NSCLC) according to two studies published in the November, 2001 issue of The Journal of Nuclear Medicine.

Reston, Virginia -- Positron Emission Tomography (PET) can have a dramatic impact on patient staging and subsequent treatment of persons recently diagnosed or with suspected recurrent non–small cell lung cancer (NSCLC) according to two studies published in the November, 2001 issue of The Journal of Nuclear Medicine. One study of 63 patients with suspected recurring disease revealed that PET scans were significantly more accurate in identifying the extent of the possible recurrent disease for 86% of the patients, whereas conventional staging was correct for only 24% of the patients. In the same study PET scans found that 33% of the patients had less extensive disease and 37% had more extensive disease than conventional evaluation using computed tomography (CT) had suggested. In cases in of recurring cancer, in which the PET scan and CT findings differed, PET was found to be correct 86% of the time, while the conventional evaluation was correct for only one patient (3%). The PET scan findings resulted in a major change in treatment for 63% of the patients with recurrent cancer. Of these, treatment for 6 patients was changed from curative to palliative care. More importantly, 9 persons who were going to receive either active palliative therapy or an invasive diagnostic procedure were spared these costly, and potentially painful treatments, when the PET scan revealed no active disease. Major changes were classified as changing the treatment intent or modality, i.e., from palliative to curative treatment or from surgery to radiotherapy. PET had a medium impact on management of 8 patients (13%), which generally meant changes in radiation treatment volume. It had a low impact on 13 patients (21%).

“Telling people they are free of active disease has an enormously reassuring psychological impact on patients, and therefore we felt that this result—while often overlooked—qualified it as a major impact of the PET study results,” stated study author Dr. Rodney J. Hicks, of the Peter MacCallum Cancer Institute in Australia.

For newly diagnosed patients, the impact of PET on their primary staging and treatment planning was also significant. PET results led to patients staged differently from conventional (i.e., CT) staging in 42% of the 153 patients. Stage IV disease was found in 11% of those patients thought to have either stage I or stage II disease under conventional staging. Nineteen patients (24%) thought to have stage III disease were found post-PET to be at stage IV.

Treatment planning for the newly diagnosed was also impacted. The study authors noted that the PET scan had a high impact (i.e., changed planned treatment) for 35% of the patients. Reflecting the large number of those with upstaged disease, 54 patients had their planned therapy change from curative to palliative, whereas for 6 patients, the planned therapy moved from palliative to curative. The PET results had a medium impact on 25% of the newly diagnosed patients. These changes were mostly in the area of radiation treatment.

According to the authors, because of its ability to more accurately stage disease compared with convention evaluation, PET also demonstrated its ability to produce accurate prediction of survival among patients.

"The impact of PET on patient care and well-being cannot be overstated," said author Rodney Hicks. "By allowing patients with a poor prognosis to receive palliative rather than futile curative therapy, the patient is spared the often harrowing effects of the treatments. The costs are also reduced as unproductive treatments are reduced."

Lung cancer is the most common cause of cancer death in western society, and is increasing in incidence. In the United States, the American Cancer Society estimates that 164,000 Americans were diagnosed with the disease in 2000, and an estimated 156,900 died, the largest number of deaths of any single cancer.


Story Source:

The above story is based on materials provided by Society Of Nuclear Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Society Of Nuclear Medicine. "PET Changes Staging And Treatment For Newly Diagnosed And Recurrent Lung Cancer Patients." ScienceDaily. ScienceDaily, 5 November 2001. <www.sciencedaily.com/releases/2001/11/011105073013.htm>.
Society Of Nuclear Medicine. (2001, November 5). PET Changes Staging And Treatment For Newly Diagnosed And Recurrent Lung Cancer Patients. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2001/11/011105073013.htm
Society Of Nuclear Medicine. "PET Changes Staging And Treatment For Newly Diagnosed And Recurrent Lung Cancer Patients." ScienceDaily. www.sciencedaily.com/releases/2001/11/011105073013.htm (accessed October 20, 2014).

Share This



More Matter & Energy News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

'Robotic Eyes' Helps Japan's Bipedal Bot Run Faster

'Robotic Eyes' Helps Japan's Bipedal Bot Run Faster

Reuters - Innovations Video Online (Oct. 16, 2014) Japanese researcher uses an eye-sensor camera to enable a bipedal robot to balance itself, while running on a treadmill. Jim Drury reports. Video provided by Reuters
Powered by NewsLook.com
Lockheed Martin's Fusion Concept Basically An Advertisement

Lockheed Martin's Fusion Concept Basically An Advertisement

Newsy (Oct. 15, 2014) Lockheed Martin announced plans to develop the first-ever compact nuclear fusion reactor. But some experts said the excitement is a little premature. Video provided by Newsy
Powered by NewsLook.com
First Confirmed Case Of Google Glass Addiction

First Confirmed Case Of Google Glass Addiction

Buzz60 (Oct. 15, 2014) A Google Glass user was treated for Internet Addiction Disorder caused from overuse of the device. Morgan Manousos (@MorganManousos) has the details on how many hours he spent wearing the glasses, and what his symptoms were. Video provided by Buzz60
Powered by NewsLook.com
Science Proves Why Pizza Is So Delicious

Science Proves Why Pizza Is So Delicious

Buzz60 (Oct. 15, 2014) The American Chemical Society’s latest video about chemistry in every day life breaks down pizza, and explains exactly why it's so delicious. Gillian Pensavalle (@GillianWithaG) has the video. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Space & Time

Matter & Energy

Computers & Math

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins